Assessing pathological detoxification fear among methadone maintenance patients: The DFSS

J. B. Milby, R. H. Gurwitch, A. A. Hohmann, D. J. Wiebe

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

This study assessed the reliability, validity, discriminative accuracy, and factor structure of the Detoxification Fear Survey Schedule (DFSS). Prevalence of detoxification fear and its correlates also were assessed. Random samples from three geographically, culturally, and racially disparate populations (N = 271) of treated opioid addicts were used. The DFSS had a test-retest r = .935 and demonstrated several indicants of validity. A briefer version (DFSS-14) showed superior psychometric properties and could identify correctly 81% of detox fear subjects while it excluded 55% of nonfear subjects. The DFSS-14 had a replicated three-factor structure that accounted for 62.1% of total item variance in the validation sample. Factor two, probably best named dose reduction fear, was replicated in all populations. A cut-off score set at the nonfear mean is recommended for clinical use. A brief clinical interview of positive scorers quickly should eliminate false positives and, thus, efficiently identify most of those with detoxification fear.

Original languageEnglish (US)
Pages (from-to)528-538
Number of pages11
JournalJournal of Clinical Psychology
Volume43
Issue number5
StatePublished - 1987

Fingerprint

Methadone
Fear
Appointments and Schedules
Surveys and Questionnaires
Psychometrics
Reproducibility of Results
Opioid Analgesics
Population
Interviews

ASJC Scopus subject areas

  • Psychology(all)
  • Clinical Psychology

Cite this

Milby, J. B., Gurwitch, R. H., Hohmann, A. A., & Wiebe, D. J. (1987). Assessing pathological detoxification fear among methadone maintenance patients: The DFSS. Journal of Clinical Psychology, 43(5), 528-538.

Assessing pathological detoxification fear among methadone maintenance patients : The DFSS. / Milby, J. B.; Gurwitch, R. H.; Hohmann, A. A.; Wiebe, D. J.

In: Journal of Clinical Psychology, Vol. 43, No. 5, 1987, p. 528-538.

Research output: Contribution to journalArticle

Milby, JB, Gurwitch, RH, Hohmann, AA & Wiebe, DJ 1987, 'Assessing pathological detoxification fear among methadone maintenance patients: The DFSS', Journal of Clinical Psychology, vol. 43, no. 5, pp. 528-538.
Milby, J. B. ; Gurwitch, R. H. ; Hohmann, A. A. ; Wiebe, D. J. / Assessing pathological detoxification fear among methadone maintenance patients : The DFSS. In: Journal of Clinical Psychology. 1987 ; Vol. 43, No. 5. pp. 528-538.
@article{7b84325b96ad4a6a86df6849aec46bc1,
title = "Assessing pathological detoxification fear among methadone maintenance patients: The DFSS",
abstract = "This study assessed the reliability, validity, discriminative accuracy, and factor structure of the Detoxification Fear Survey Schedule (DFSS). Prevalence of detoxification fear and its correlates also were assessed. Random samples from three geographically, culturally, and racially disparate populations (N = 271) of treated opioid addicts were used. The DFSS had a test-retest r = .935 and demonstrated several indicants of validity. A briefer version (DFSS-14) showed superior psychometric properties and could identify correctly 81{\%} of detox fear subjects while it excluded 55{\%} of nonfear subjects. The DFSS-14 had a replicated three-factor structure that accounted for 62.1{\%} of total item variance in the validation sample. Factor two, probably best named dose reduction fear, was replicated in all populations. A cut-off score set at the nonfear mean is recommended for clinical use. A brief clinical interview of positive scorers quickly should eliminate false positives and, thus, efficiently identify most of those with detoxification fear.",
author = "Milby, {J. B.} and Gurwitch, {R. H.} and Hohmann, {A. A.} and Wiebe, {D. J.}",
year = "1987",
language = "English (US)",
volume = "43",
pages = "528--538",
journal = "Journal of Clinical Psychology",
issn = "0021-9762",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Assessing pathological detoxification fear among methadone maintenance patients

T2 - The DFSS

AU - Milby, J. B.

AU - Gurwitch, R. H.

AU - Hohmann, A. A.

AU - Wiebe, D. J.

PY - 1987

Y1 - 1987

N2 - This study assessed the reliability, validity, discriminative accuracy, and factor structure of the Detoxification Fear Survey Schedule (DFSS). Prevalence of detoxification fear and its correlates also were assessed. Random samples from three geographically, culturally, and racially disparate populations (N = 271) of treated opioid addicts were used. The DFSS had a test-retest r = .935 and demonstrated several indicants of validity. A briefer version (DFSS-14) showed superior psychometric properties and could identify correctly 81% of detox fear subjects while it excluded 55% of nonfear subjects. The DFSS-14 had a replicated three-factor structure that accounted for 62.1% of total item variance in the validation sample. Factor two, probably best named dose reduction fear, was replicated in all populations. A cut-off score set at the nonfear mean is recommended for clinical use. A brief clinical interview of positive scorers quickly should eliminate false positives and, thus, efficiently identify most of those with detoxification fear.

AB - This study assessed the reliability, validity, discriminative accuracy, and factor structure of the Detoxification Fear Survey Schedule (DFSS). Prevalence of detoxification fear and its correlates also were assessed. Random samples from three geographically, culturally, and racially disparate populations (N = 271) of treated opioid addicts were used. The DFSS had a test-retest r = .935 and demonstrated several indicants of validity. A briefer version (DFSS-14) showed superior psychometric properties and could identify correctly 81% of detox fear subjects while it excluded 55% of nonfear subjects. The DFSS-14 had a replicated three-factor structure that accounted for 62.1% of total item variance in the validation sample. Factor two, probably best named dose reduction fear, was replicated in all populations. A cut-off score set at the nonfear mean is recommended for clinical use. A brief clinical interview of positive scorers quickly should eliminate false positives and, thus, efficiently identify most of those with detoxification fear.

UR - http://www.scopus.com/inward/record.url?scp=0023232473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023232473&partnerID=8YFLogxK

M3 - Article

C2 - 3667947

AN - SCOPUS:0023232473

VL - 43

SP - 528

EP - 538

JO - Journal of Clinical Psychology

JF - Journal of Clinical Psychology

SN - 0021-9762

IS - 5

ER -